Literature DB >> 14616564

Decreased phagocytic capacity of autotransplanted splenic tissue.

Eric Smith1, Neville J De Young, Paul A Drew.   

Abstract

BACKGROUND: Asplenic patients have an increased risk of infections. Operations such as autotransplantation have been proposed to restore functional splenic tissue after splenectomy, but the protective value of this tissue is unclear. Immune responses such as production of antibody remain impaired in humans and animals even when such tissue is present, and clearance of particles from the blood is reported to be less efficient than by normal spleen tissue. The present study investigated the phagocytic capacity of cells in the regenerated tissue in vitro, free of the confounding effects of hepatic clearance.
METHODS: Single cell suspensions were prepared from splenic tissue from rats 6 months after splenic autotransplantation or sham operation. Phagocytosis of killed, fluorescein-labelled bacteria was measured by flow cytometry.
RESULTS: Autotransplanted tissue contained fewer phagocytic cells than normal tissue, and these cells phagocytosed less per cell. Phagocytosis by spleen cells was dependent on heat-labile opsonic factors.
CONCLUSIONS: Autotransplanted splenic tissue does not restore the phagocytic capacity lost following splenectomy.

Entities:  

Mesh:

Year:  2003        PMID: 14616564     DOI: 10.1046/j.1445-2197.2003.02819.x

Source DB:  PubMed          Journal:  ANZ J Surg        ISSN: 1445-1433            Impact factor:   1.872


  2 in total

1.  A solution to the negative effects of splenectomy during colorectal trauma and surgery: an experimental study on splenic autotransplantation to the groin area.

Authors:  Bora Karip; Metin Mestan; Özgen Işık; Metin Keskin; Kafkas Çelik; Yalın İşcan; Kemal Memişoğlu
Journal:  BMC Surg       Date:  2015-12-18       Impact factor: 2.102

2.  Thoracic splenosis mimicking a pleuropneumonia: A case report.

Authors:  Aurélie Baldolli; Solène Coeuret; Vincent Le Pennec; Denis Agostini; Renaud Verdon
Journal:  Medicine (Baltimore)       Date:  2017-07       Impact factor: 1.889

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.